Medical University of South Carolina NCORP Minority/Underserved Community Site

项目摘要 南卡罗来纳州医科大学/霍林斯癌症中心（MUSC/HCC）成立 2014年作为少数族裔服务不足的研究中心，通过以下方式扩大和增强NCORP试验产品组合 种族/民族多样化的患者和来自其他医疗服务不足群体的患者 参与NCORP研究，分享关于少数族裔征聘和保留的专门知识和经验， 在NCORP社区内的文化多样性，并有助于发展和 实施癌症护理和癌症分娩研究。在本项目期间， MUSC NCORP-MU由两个MUSC/HCC子分支机构和五个社区组成 肿瘤学主要分支机构，通过以下方式为NCORP计划做出了重大贡献： 有效和高效地增加不同的患者群体和领导， 临床试验、癌症健康差异和癌症护理提供的科学议程 research.这些成就是通过高度投资和 由Chanita Hughes-Halbert博士组成的跨学科调查团队（精神病学和 Behavioral Sciences），Marvella E.福特，博士（公共卫生科学），卡罗琳D。Britten，MD （Medical Oncology）和大卫T.马歇尔，医学博士（放射肿瘤学），曾携手合作， 与MUSC/HCC的临床研究运营领导人合作，建立和管理 强大的临床研究操作，为NCORP增加价值。这个领导团队也在 与其他致力于临床和癌症控制的研究人员合作， 提供者，癌症患者和幸存者在我们的集水区，以促进所有类型的癌症 通过NCORP研究基地进行研究。MUSC NCORP-MU旨在提高公平性 以及少数种族/族裔和其他医疗服务不足的人获得临床研究的机会 为了改善癌症的结果，提高癌症护理服务的质量， 减少南卡罗来纳州和美国各地社区的癌症健康差距。

PROJECT SUMMARY The Medical University of South Carolina/Hollings Cancer Center (MUSC/HCC) was established as a Minority Underserved site in 2014 to expand and enhance the NCORP trial portfolio by accruing racially/ethnically diverse patients and those from other medically underserved groups into NCORP studies, share expertise and experience on minority recruitment and retention and cultural diversity within the NCORP community, and contribute to the development and implementation of cancer care and cancer delivery research. During the current project period, the MUSC NCORP-MU, which is comprised of two MUSC/HCC sub-affiliates and five community oncology primary affiliates, has made significant contributions to the NCORP program through the effective and efficient accrual of diverse patient populations and leadership that has shaped the scientific agenda for clinical trials, cancer health disparities, and cancer care delivery research. These accomplishments were made possible through a highly invested and transdisciplinary investigative team consisting of Chanita Hughes-Halbert, PhD (Psychiatry & Behavioral Sciences), Marvella E. Ford, PhD (Public Health Sciences), Carolyn D. Britten, MD (Medical Oncology), and David T. Marshall, MD (Radiation Oncology) that has worked hand-in- hand with the clinical research operational leaders at the MUSC/HCC to establish and manage a robust clinical research operation to add value to NCORP. This leadership team has also worked collaboratively with other committed clinical and cancer control researchers, oncology care providers, cancer patients, and survivors in our catchment areas to advance all types of cancer research through the NCORP research bases. The MUSC NCORP-MU aims to improve equity and access to clinical research among racial/ethnic minorities and other medically underserved groups in order to improve cancer outcomes, enhance the quality of cancer care delivery, and reduce cancer health disparities within South Carolina and communities across the US.